These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 1422299)

  • 1. Lack of deleterious effect of slow-release sodium fluoride treatment on cortical bone histology and quality in osteoporotic patients.
    Zerwekh JE; Antich PP; Sakhaee K; Prior J; Gonzales J; Gottschalk F; Pak CY
    Bone Miner; 1992 Jul; 18(1):65-76. PubMed ID: 1422299
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of slow-release sodium fluoride on cancellous bone histology and connectivity in osteoporosis.
    Zerwekh JE; Hagler HK; Sakhaee K; Gottschalk F; Peterson RD; Pak CY
    Bone; 1994; 15(6):691-9. PubMed ID: 7873299
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Measurement of intrinsic bone quality in vivo by reflection ultrasound: correction of impaired quality with slow-release sodium fluoride and calcium citrate.
    Antich PP; Pak CY; Gonzales J; Anderson J; Sakhaee K; Rubin C
    J Bone Miner Res; 1993 Mar; 8(3):301-11. PubMed ID: 8456586
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment by reflection ultrasound method of the effect of intermittent slow-release sodium fluoride-calcium citrate therapy on material strength of bone.
    Zerwekh JE; Antich PP; Sakhaee K; Gonzales J; Gottschalk F; Pak CY
    J Bone Miner Res; 1991 Mar; 6(3):239-44. PubMed ID: 2035350
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Slow-release sodium fluoride in the management of postmenopausal osteoporosis. A randomized controlled trial.
    Pak CY; Sakhaee K; Piziak V; Peterson RD; Breslau NA; Boyd P; Poindexter JR; Herzog J; Heard-Sakhaee A; Haynes S; Adams-Huet B; Reisch JS
    Ann Intern Med; 1994 Apr; 120(8):625-32. PubMed ID: 8135445
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reflection ultrasound velocities and histomorphometric and connectivity analyses: correlations and effect of slow-release sodium fluoride.
    Zerwekh JE; Antich PP; Mehta S; Sakhaee K; Gottschalk F; Pak CY
    J Bone Miner Res; 1997 Dec; 12(12):2068-75. PubMed ID: 9421239
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of intermittent slow-release sodium fluoride and continuous calcium citrate therapy on calcitropic hormones, biochemical markers of bone metabolism, and blood chemistry in postmenopausal osteoporosis.
    Zerwekh JE; Padalino P; Pak CY
    Calcif Tissue Int; 1997 Oct; 61(4):272-8. PubMed ID: 9312196
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of postmenopausal osteoporosis with slow-release sodium fluoride. Final report of a randomized controlled trial.
    Pak CY; Sakhaee K; Adams-Huet B; Piziak V; Peterson RD; Poindexter JR
    Ann Intern Med; 1995 Sep; 123(6):401-8. PubMed ID: 7639438
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Marked decrease in trabecular bone quality after five years of sodium fluoride therapy--assessed by biomechanical testing of iliac crest bone biopsies in osteoporotic patients.
    Søgaard CH; Mosekilde L; Richards A; Mosekilde L
    Bone; 1994; 15(4):393-9. PubMed ID: 7917577
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of different regimens of sodium fluoride treatment for osteoporosis on the structure, remodeling and mineralization of bone.
    Balena R; Kleerekoper M; Foldes JA; Shih MS; Rao DS; Schober HC; Parfitt AM
    Osteoporos Int; 1998; 8(5):428-35. PubMed ID: 9850350
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of osteoporosis with human parathyroid peptide and observations on effect of sodium fluoride.
    Reeve J; Davies UM; Hesp R; McNally E; Katz D
    BMJ; 1990 Aug; 301(6747):314-8. PubMed ID: 2393738
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safe and effective treatment of osteoporosis with intermittent slow release sodium fluoride: augmentation of vertebral bone mass and inhibition of fractures.
    Pak CY; Sakhaee K; Zerwekh JE; Parcel C; Peterson R; Johnson K
    J Clin Endocrinol Metab; 1989 Jan; 68(1):150-9. PubMed ID: 2909549
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effects of the combined raloxifene-sodium fluoride therapy on bone mass and bone turnover in women with postmenopausal osteoporosis].
    Celi M; Letizia C; Ragno A; Minisola S; D'Erasmo E; Mazzuoli GF
    Minerva Med; 2002 Dec; 93(6):471-8. PubMed ID: 12515970
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of intermittent therapy with a slow-release fluoride preparation.
    Pak CY; Sakhaee K; Zerwekh JE
    J Bone Miner Res; 1990 Mar; 5 Suppl 1():S149-55. PubMed ID: 2339625
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sustained-release sodium fluoride in the treatment of the elderly with established osteoporosis.
    Rubin CD; Pak CY; Adams-Huet B; Genant HK; Li J; Rao DS
    Arch Intern Med; 2001 Oct; 161(19):2325-33. PubMed ID: 11606148
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of prolonged fluoride therapy for osteoporosis: bone composition and histology.
    Lundy MW; Wergedal JE; Teubner E; Burnell J; Sherrard D; Baylink DJ
    Bone; 1989; 10(5):321-7. PubMed ID: 2605048
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of nonrandomized trials with slow-release sodium fluoride with a randomized placebo-controlled trial in postmenopausal osteoporosis.
    Pak CY; Adams-Huet B; Sakhaee K; Bell NH; Licata A; Johnston C; Rubin B; Bonnick S; Piziak V; Graham H; Ballard J; Berger R; Fears W; Breslau N; Rubin C
    J Bone Miner Res; 1996 Feb; 11(2):160-8. PubMed ID: 8822339
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anabolic effects of fluoride on bone.
    Pak CY; Zerwekh JE; Antich P
    Trends Endocrinol Metab; 1995 Sep; 6(7):229-34. PubMed ID: 11540313
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of fluoride treatment on the fracture rate in postmenopausal women with osteoporosis.
    Riggs BL; Hodgson SF; O'Fallon WM; Chao EY; Wahner HW; Muhs JM; Cedel SL; Melton LJ
    N Engl J Med; 1990 Mar; 322(12):802-9. PubMed ID: 2407957
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intravenous ibandronate or sodium-fluoride--a 3.5 years study on bone density and fractures in Crohn's disease patients with osteoporosis.
    Klaus J; Reinshagen M; Herdt K; Adler G; von Boyen GB; von Tirpitz C
    J Gastrointestin Liver Dis; 2011 Jun; 20(2):141-8. PubMed ID: 21725510
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.